» Articles » PMID: 37434171

Integrating Plan Complexity and Dosiomics Features with Deep Learning in Patient-specific Quality Assurance for Volumetric Modulated Arc Therapy

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2023 Jul 11
PMID 37434171
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the feasibility and performance of deep learning (DL) models combined with plan complexity (PC) and dosiomics features in the patient-specific quality assurance (PSQA) for patients underwent volumetric modulated arc therapy (VMAT).

Methods: Total of 201 VMAT plans with measured PSQA results were retrospectively enrolled and divided into training and testing sets randomly at 7:3. PC metrics were calculated using house-built algorithm based on Matlab. Dosiomics features were extracted and selected using Random Forest (RF) from planning target volume (PTV) and overlap regions with 3D dose distributions. The top 50 dosiomics and 5 PC features were selected based on feature importance screening. A DL DenseNet was adapted and trained for the PSQA prediction.

Results: The measured average gamma passing rate (GPR) of these VMAT plans was 97.94% ± 1.87%, 94.33% ± 3.22%, and 87.27% ± 4.81% at the criteria of 3%/3 mm, 3%/2 mm, and 2%/2 mm, respectively. Models with PC features alone demonstrated the lowest area under curve (AUC). The AUC and sensitivity of PC and dosiomics (D) combined model at 2%/2 mm were 0.915 and 0.833, respectively. The AUCs of DL models were improved from 0.943, 0.849, 0.841 to 0.948, 0.890, 0.942 in the combined models (PC + D + DL) at 3%/3 mm, 3%/2 mm and 2%/2 mm, respectively. A best AUC of 0.942 with a sensitivity, specificity and accuracy of 100%, 81.8%, and 83.6% was achieved with combined model (PC + D + DL) at 2%/2 mm.

Conclusions: Integrating DL with dosiomics and PC metrics is promising in the prediction of GPRs in PSQA for patients underwent VMAT.

Citing Articles

The impact of plan complexity on calculation and measurement-based pre-treatment verifications for sliding-window intensity-modulated radiotherapy.

Li S, Luo H, Tan X, Qiu T, Yang X, Feng B Phys Imaging Radiat Oncol. 2024; 31:100622.

PMID: 39220115 PMC: 11364123. DOI: 10.1016/j.phro.2024.100622.

References
1.
de Jong R, Crama K, Visser J, van Wieringen N, Wiersma J, Geijsen E . Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit. Radiat Oncol. 2020; 15(1):162. PMC: 7371470. DOI: 10.1186/s13014-020-01597-1. View

2.
McDonald D, Jacqmin D, Mart C, Koch N, Peng J, Ashenafi M . Validation of a modern second-check dosimetry system using a novel verification phantom. J Appl Clin Med Phys. 2017; 18(1):170-177. PMC: 5689885. DOI: 10.1002/acm2.12025. View

3.
Valdes G, Scheuermann R, Hung C, Olszanski A, Bellerive M, Solberg T . A mathematical framework for virtual IMRT QA using machine learning. Med Phys. 2016; 43(7):4323. DOI: 10.1118/1.4953835. View

4.
Jin X, Yi J, Zhou Y, Yan H, Han C, Xie C . Comparison of whole-field simultaneous integrated boost VMAT and IMRT in the treatment of nasopharyngeal cancer. Med Dosim. 2013; 38(4):418-23. DOI: 10.1016/j.meddos.2013.05.004. View

5.
Yi J, Han C, Zheng X, Zhou Y, Deng Z, Xie C . Individual volume-based 3D gamma indices for pretreatment VMAT QA. J Appl Clin Med Phys. 2017; 18(3):28-36. PMC: 5689866. DOI: 10.1002/acm2.12062. View